- Home
- TRML vs SVM Comparison
TRML vs SVM Comparison
Compare TRML & SVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRML
- SVM
- Stock Information
- Founded
- TRML 2021
- SVM N/A
- Country
- TRML United States
- SVM Canada
- Employees
- TRML N/A
- SVM N/A
- Industry
- TRML Biotechnology: Pharmaceutical Preparations
- SVM Precious Metals
- Sector
- TRML Health Care
- SVM Basic Materials
- Exchange
- TRML Nasdaq
- SVM Nasdaq
- Market Cap
- TRML 1.2B
- SVM 1.4B
- IPO Year
- TRML N/A
- SVM N/A
- Fundamental
- Price
- TRML $47.90
- SVM $7.04
- Analyst Decision
- TRML Hold
- SVM Strong Buy
- Analyst Count
- TRML 12
- SVM 1
- Target Price
- TRML $47.04
- SVM $6.75
- AVG Volume (30 Days)
- TRML 2.1M
- SVM 7.1M
- Earning Date
- TRML 11-06-2025
- SVM 11-06-2025
- Dividend Yield
- TRML N/A
- SVM 0.35%
- EPS Growth
- TRML N/A
- SVM N/A
- EPS
- TRML N/A
- SVM 0.25
- Revenue
- TRML N/A
- SVM $308,064,000.00
- Revenue This Year
- TRML N/A
- SVM $6.17
- Revenue Next Year
- TRML N/A
- SVM $35.69
- P/E Ratio
- TRML N/A
- SVM $28.51
- Revenue Growth
- TRML N/A
- SVM 35.50
- 52 Week Low
- TRML $11.56
- SVM $2.87
- 52 Week High
- TRML $48.27
- SVM $7.34
- Technical
- Relative Strength Index (RSI)
- TRML 91.37
- SVM 77.60
- Support Level
- TRML $47.83
- SVM $6.28
- Resistance Level
- TRML $47.94
- SVM $7.34
- Average True Range (ATR)
- TRML 0.11
- SVM 0.34
- MACD
- TRML -0.63
- SVM 0.11
- Stochastic Oscillator
- TRML 38.14
- SVM 85.93
About TRML Tourmaline Bio Inc.
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.
About SVM Silvercorp Metals Inc.
Silvercorp Metals Inc is a mineral exploration company, engaged in the acquisition, exploration, development, and mining of mineral properties. The company's producing mines are located in China, and exploration and development projects are located in China and Ecuador. Its project portfolio comprises the El Domo copper-gold and the Condor gold project in Ecuador. In addition, it operates several silver-lead-zinc mines at the Ying Mining District in Henan Province, China, and the GC silver-lead-zinc mine in Guangdong Province, China. A majority of the company's revenue is generated through the sale of silver concentrates. Its reportable operating segments are the Ying Mining District and GC Mine in China, which derive maximum revenue, and the El Domo and Condor projects in Ecuador.